Stockscreener 앱 받기
102.67
0.08%
-0.085
시장 영업 전:
106.00
3.325
+3.24%
전일 마감가:
$102.76
열려 있는:
$105
하루 거래량:
169.33K
Relative Volume:
3.30
시가총액:
$4.66B
수익:
-
순이익/손실:
-
주가수익비율:
-
EPS:
-
순현금흐름:
-
1주 성능:
-19.69%
1개월 성능:
+0.00%
6개월 성능:
+0.00%
1년 성능:
+0.00%
1일 변동 폭
$99.61
$107.06
1주일 범위
$99.47
$130.96
52주 변동 폭
$88.00
$138.70
Billiontoone Inc Stock (BLLN) Company Profile
BLLN을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
BLLN
Billiontoone Inc
|
102.67 | 4.67B | 0 | 0 | 0 | 0.00 |
|
TMO
Thermo Fisher Scientific Inc
|
575.24 | 218.08B | 43.74B | 6.58B | 6.11B | 17.31 |
|
DHR
Danaher Corp
|
227.13 | 161.37B | 24.27B | 3.50B | 5.02B | 4.8589 |
|
IDXX
Idexx Laboratories Inc
|
717.35 | 57.97B | 4.17B | 1.03B | 940.22M | 12.61 |
|
A
Agilent Technologies Inc
|
148.32 | 42.25B | 6.95B | 1.30B | 1.15B | 4.5714 |
|
IQV
Iqvia Holdings Inc
|
224.92 | 38.70B | 15.90B | 1.28B | 2.21B | 7.2842 |
Billiontoone Inc Stock (BLLN) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-12-01 | 개시 | BTIG Research | Buy |
| 2025-12-01 | 개시 | JP Morgan | Overweight |
| 2025-12-01 | 개시 | Jefferies | Hold |
| 2025-12-01 | 개시 | Piper Sandler | Overweight |
| 2025-12-01 | 개시 | Stifel | Buy |
| 2025-12-01 | 개시 | Wells Fargo | Equal Weight |
| 2025-12-01 | 개시 | William Blair | Outperform |
모두보기
Billiontoone Inc 주식(BLLN)의 최신 뉴스
Billiontoone, Inc. (NASDAQ:BLLN) Receives Consensus Rating of "Moderate Buy" from Brokerages - MarketBeat
BillionToOne to Report Third Quarter 2025 Financial Results on December 9, 2025 - The Manila Times
BillionToOne (NASDAQ: BLLN) schedules Q3 2025 results and call for Dec. 9, 2025 - Stock Titan
Billiontoone (NASDAQ:BLLN) Coverage Initiated by Analysts at JPMorgan Chase & Co. - Defense World
Piper Sandler initiates BillionToOne stock coverage with Overweight rating By Investing.com - Investing.com South Africa
BillionToOne stock initiated at Overweight by JPMorgan on diagnostic tech - Investing.com Canada
BillionToOne wins upbeat coverage as analysts flag growth in prenatal, cancer tests - whbl.com
BTIG initiates BillionToOne stock with Buy rating on prenatal testing growth - Investing.com Nigeria
BTIG initiates BillionToOne stock with Buy rating on prenatal testing growth By Investing.com - Investing.com South Africa
BillionToOne Analysts Praise Molecular Diagnostic Firm's IPO RallyBillionToOne (NASDAQ:BLLN) - Benzinga
BillionToOne wins bullish backing, but Jefferies and Wells Fargo urge caution - Investing.com Canada
BillionToOne Shares Fall After Jefferies Initiates Coverage at Hold - marketscreener.com
BillionToOne initiated with an Outperform at William Blair - TipRanks
BillionToOne stock initiated at Equal Weight by Wells Fargo with $110 target - Investing.com South Africa
This Joby Aviation Analyst Begins Coverage On A Bearish Note; Here Are Top 5 Initiations For Monday - Benzinga
Stifel Initiates BillionToOne at Buy With $145 Price Target - marketscreener.com
Piper Sandler Initiates BillionToOne at Overweight With $150 Price Target - marketscreener.com
JPMorgan Initiates BillionToOne at Overweight With $150 Price Target - marketscreener.com
Wells Fargo Initiates BillionToOne at Equalweight With $110 Price Target - MarketScreener
William Blair Initiates BillionToOne at Outperform - MarketScreener
BTIG Initiates BillionToOne at Buy With $160 Price Target - marketscreener.com
BillionToOne’s Hot IPO Has Analysts Onboard Early - Finimize
BillionToOne: Disrupting Diagnostics with Groundbreaking Tech - Devdiscourse
William Blair initiates coverage on BillionToOne stock with Outperform rating By Investing.com - Investing.com South Africa
BillionToOne initiated with an Equal Weight at Wells Fargo - TipRanks
William Blair initiates coverage on BillionToOne stock with Outperform rating - Investing.com
BillionToOne: A High-Growth Leader in Prenatal Genetics and Oncology with Strong Buy Rating - TipRanks
BillionToOne initiated with a Hold at Jefferies - TipRanks
BillionToOne initiated with an Overweight at Piper Sandler - TipRanks
Jefferies initiates BillionToOne stock with Hold rating, $117 price target By Investing.com - Investing.com Australia
BillionToOne initiated with a Buy at Stifel - TipRanks
BillionToOne’s Innovative Platform Poised for Growth in Reproductive Health and Oncology Markets - TipRanks
BillionToOne’s Innovative Sequencing Platform and Strong Growth Prospects Justify Buy Rating and $150 Price Target - TipRanks
BillionToOne initiated with an Overweight at JPMorgan - TipRanks
Balanced Outlook on BillionToOne, Inc.: High Growth Potential Amidst Competitive Challenges - TipRanks
BillionToOne, Inc.: Strong Market Position and Profitability Justify Buy Rating - TipRanks
Piper Sandler initiates BillionToOne stock coverage with Overweight rating - Investing.com India
Jefferies initiates BillionToOne stock with Hold rating, $117 price target - Investing.com
BillionToOne stock initiated with Buy rating at Stifel on NIPT market share gains - Investing.com India
BillionToOne stock initiated with Buy rating at Stifel on NIPT market share gains By Investing.com - Investing.com South Africa
BLLNBilliontoone Inc Stock Price and Quote - Finviz
BillionToOne, Inc. (BLLN) stock major holders - Yahoo Finance Australia
BillionToOne, Inc. (BLLN) Stock Major Holders - Yahoo! Finance Canada
IPO Stock Taps Massive Medicare Market, Soars Into Buy Range - Investor's Business Daily
BillionToOne, Inc. (BLLN) Beta - Zacks Investment Research
BLLN Stock Today: BillionToOne Closes Near Highs as Post‑IPO Rally Accelerates (Nov. 24, 2025) - ts2.tech
BillionToOne, Inc. (BLLN) Analyst Insights, Price Targets & Recommendations - Yahoo! Finance Canada
Billiontoone Inc (BLLN) 재무 분석
Billiontoone Inc (BLLN)에 대한 금융 데이터가 없습니다. 더 많은 정보를 위해 다른 주식을 확인해보세요.
매출
순이익
현금흐름
주당 순 이익
0.86%
1.61%
자본화:
|
볼륨(24시간):